Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD study of beta-lactam and fluoroquinolone antibiotics in ICU patients
NL-OMON43959Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in bacterial disease and sepsis, sponsored by Erasmus MC. Primary endpoints: Achievement of beta-lactam PK/PD targets and Achievement of fluoroquinolone PK/PD targets. Started Jan 2016; status: recruiting.
02
Conditions
bacterial diseasesepsis
Beyond the preview
Go deeper on NL-OMON43959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43959.